Tutorials
Forma Therapeutics Holdings Inc logo

Forma Therapeutics Holdings Inc

$ 11.85 +0.65 (+5.8%) 08:09 PM EST
P/E:
At Loss
P/B:
1.37
Market Cap:
$ 567.05M
Enterprise V:
$ 203.70M
Volume:
180.66K
Avg Vol (2M):
622.09K
Volume:
180.66K
Market Cap $:
567.05M
PE Ratio:
At Loss
Avg Vol (2-Month):
622.09K
Enterprise Value $:
203.70M
PB Ratio:
1.37
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Forma Therapeutics Holdings Inc
NAICS : 541714 SIC : 2834
300 North Beacon Street, Suite 501, Watertown, MA, USA, 02472
Description
Forma Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. The firm's pipeline products are Etavopivat, FT-7051, FT-8225, and others.
Name Current Vs Industry Vs History
Cash-To-Debt 12.16
Equity-to-Asset 0.87
Debt-to-Equity 0.08
Debt-to-EBITDA -0.17
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -100
3-Year EPS without NRI Growth Rate -375.3
3-Year FCF Growth Rate 35.3

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 83.75
9-Day RSI 79.52
14-Day RSI 75.53
6-1 Month Momentum % -26.23
12-1 Month Momentum % -64.51

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.74
Quick Ratio 12.74
Cash Ratio 11.83

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -61

Financials (Next Earnings Date:2022-11-11 Est.)

FMTX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:FMTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -4
Beta 0
Volatility % 54.71
14-Day RSI 75.53
14-Day ATR ($) 0.718851
20-Day SMA ($) 9.3145
12-1 Month Momentum % -64.51
52-Week Range ($) 4.95 - 25.21
Shares Outstanding (Mil) 47.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Forma Therapeutics Holdings Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More